Raykov Rosty
Transaction: 08/03/2026
SELL
Change
-10,000
Price
$9.58
Filing
08/04/2026
Type
SELL
Fennec Pharmaceuticals Inc.
FENC • Biotechnology
$12.39
▼ -0.16 (-1.27%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$451.37M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 199.0%Manageable debt level · 0Healthy liquidity · 6.34Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:13 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$12.39
Change-1.27%
Shares Out36.43M
Market Cap$451.37M
Enterprise Value$410.12M
52W Range5.65 - 13.25
Beta1.07
P/E-138.84
P/S7.62
P/B10.63
P/FCF-221.26
EV/Sales6.93
Price$12.39
Change-1.27%
Shares Out36.43M
Market Cap$451.37M
Enterprise Value$410.12M
52W Range5.65 - 13.25
Beta1.07
P/E-138.84
P/S7.62
P/B10.63
P/FCF-221.26
EV/Sales6.93
EV/EBITDA-170.74
EV/FCF-201.04
Earnings Yield-0.72%
FCF Yield-0.45%
Dividend Yield0.00%
Gross Margin91.57%
Oper. Margin-14.22%
Profit Margin-21.82%
Debt/Eq0.00
Current Ratio6.34
Quick Ratio6.19
Target$16.00
Target Upside29.14%
Target Median$16.00
Target Range16.00 - 16.00
Volume189.99K
Avg Volume233.21K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
50
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
57/100
Why this score▼
Positive revenue growth · 199.0%Manageable debt level · 0Healthy liquidity · 6.34Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
100/100
Bullish
Bullish
8
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$16.00
Mean
$16.00
Median
$16.00
High
$16.00
Insider Transactions
Recent executive and insider activity
Andrade Robert
Transaction: 07/31/2026
BUY
Change
+1,703
Price
Not reported
Filing
08/03/2026
Type
BUY
Raykov Rosty
Transaction: 07/31/2026
BUY
Change
+2,778
Price
Not reported
Filing
08/03/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Raykov Rosty | SELL | -10,000 | $9.58 | 08/03/2026 | 08/04/2026 |
| Andrade Robert | BUY | +1,703 | Not reported | 07/31/2026 | 08/03/2026 |
| Raykov Rosty | BUY | +2,778 | Not reported | 07/31/2026 | 08/03/2026 |
| Hackman Jeffrey S. | BUY | +1,159 | Not reported | 07/31/2026 | 08/03/2026 |
| Cioffi Christiana Marie | BUY | +156 | Not reported | 07/31/2026 | 08/03/2026 |
| Evans Terry L | BUY | +168 | Not reported | 07/31/2026 | 08/03/2026 |
| Sayad Pierre Sargis | BUY | +168 | Not reported | 07/31/2026 | 08/03/2026 |
| Raykov Rosty | BUY | +2,778 | Not reported | 07/01/2026 | 07/02/2026 |
| Raykov Rosty | SELL | -15,597 | $2.45 | 07/01/2026 | 07/02/2026 |
| Cioffi Christiana Marie | BUY | +156 | Not reported | 06/30/2026 | 07/01/2026 |
| Andrade Robert | BUY | +1,703 | Not reported | 06/30/2026 | 07/01/2026 |
| Hackman Jeffrey S. | BUY | +1,159 | Not reported | 06/30/2026 | 07/01/2026 |
| Sayad Pierre Sargis | BUY | +168 | Not reported | 06/30/2026 | 07/01/2026 |
| Evans Terry L | BUY | +168 | Not reported | 06/30/2026 | 07/01/2026 |
| RALLIS CHRIS A | BUY | +20,000 | $8.70 | 06/10/2026 | 06/10/2026 |
| Islam Khalid | BUY | +25,000 | $8.70 | 06/10/2026 | 06/10/2026 |
| Cook Jodi A | BUY | +20,000 | $8.70 | 06/10/2026 | 06/10/2026 |
| Brughera Marco Maria | BUY | +20,000 | $8.70 | 06/10/2026 | 06/10/2026 |
| Raykov Rosty | SELL | -9,747 | $9.62 | 06/01/2026 | 06/02/2026 |
| Raykov Rosty | SELL | -15,597 | $2.45 | 06/01/2026 | 06/02/2026 |